AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $8,030,422 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Notice of Annual General Meeting/Proxy Form
1AD released this announcement to the ASX on 29 October 2021, 8:56. The announcement is not marked as price sensitive, and is 27 page(s) in length and 776.32kb in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Notice of Annual General Meeting/Proxy Form | 29 October 2021, 8:56 |
| Virtual Meeting Voting and Registration Guide | 29 October 2021, 8:53 |
| Jobkeeper s323DB Notice | 29 October 2021, 8:52 |
| Change of Director's Interest Notice | 28 October 2021, 8:15 |
If you were already registered, log in here.
If you were already registered, log in here.